← Eichor
Study identifier: NCT03135327 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Applications of Advanced Ophthalmic Imaging

Condition: Multiple Sclerosis · Dry Eye Syndromes · Diabetic Retinopathy  ·  Sponsor: University of Miami

PhaseNA
Planned participants5000
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersYes

About this study

The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medical food (Ocufolin) for 6 months.

This description comes directly from the study's public registry record.

Talk to the study team

Jianhua Wang, MD, PhD  ·  3054825010  ·  jwang3@med.miami.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Bascom Palmer Eye InstituteMiami, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03135327